Speed of Clinical Improvement in the Real-World Setting from Patient-Reported Psoriasis Symptoms and Signs Diary (PSSD): Secondary Outcomes from the Psoriasis Study of Health Outcomes (PSoHO) Through 12 Weeks.

Adam Reich Andreas Pinter Julia-Tatjana Maul Ronald B Vender Tiago TorresA BrnabicNatalie HaustrupC ReedC SchusterE Riedl

Published in: Journal of the European Academy of Dermatology and Venereology : JEADV (2023)

Treatment with anti-IL-17A biologics, particularly ixekizumab, resulted in rapid and sustained patient-reported improvements in psoriasis symptoms and signs compared with other biologics in a real-world setting.

Keyphrases

patient reported
atopic dermatitis
sleep quality
combination therapy
loop mediated isothermal amplification